Wells Fargo & Company »

Biondvax Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Biondvax Pharmaceuticals (SCNI) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Biondvax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biondvax Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biondvax Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $12 20 0.60
2023-09-30 $17 20 0.85
2023-06-30 $28 20 1.40
2022-12-31 $59 20 2.95

More positions owned by Wells Fargo & Company

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Ishares Tr Core S&p500 Etf Put Option (IVV)
Vanguard Index Fds Mid Cap Etf Put Option (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Ttl Stk (ITOT)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
NVIDIA Corporation Put Option (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
UnitedHealth (UNH)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Wells Fargo & Company

Top funds holding Biondvax Pharmaceuticals

Armistice Capital
Citadel Advisors
Millennium Management
Rhumbline Advisers
Morgan Stanley
UBS Group
Credit Agricole
Main Street Group
Aspire Private Capital
Global Retirement Partners
Qube Research & Technologies
Royal Bank of Canada

View all funds holding Biondvax Pharmaceuticals